与TBX1变异相关的家族性缩性心肌病变
Jie Zhang1, Yafei Deng1, Yaxin Huang1
1Department of Medical Genetics, NHC Key Laboratory of Healthy Birth and Birth Defect Prevention in Western China, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, PR China.
European journal of medical genetics
|October 23, 2025
概括
在一个中国家庭中,T-box转录因子1 (TBX1) 基因的新奇突变被确定为导致高伤心肌病 (HCM) 的原因. 这一发现确立了TBX1和HCM之间的新遗传联系.
科学领域:
- 遗传学 遗传学 是一个
- 心血管医学 心血管医学
- 分子生物学分子生物学
背景情况:
- 增高性心肌病变 (HCM) 是一种普遍存在的遗传性心血管疾病,具有多种遗传原因.
- T-box转录因子1 (TBX1) 基因以其在先天性心血管缺陷中的作用而闻名,但以前没有与HCM有关.
研究的目的:
- 为了研究一个中国家庭中高性心肌病 (HCM) 的遗传基础.
- 为了识别与HCM相关的新型基因突变.
- 探索TBX1基因在HCM病原发生中的潜在作用.
主要方法:
- 整体外体测序 (WES) 用于检测受影响家庭成员的突变.
- 桑格测序证实了已识别的突变,并评估了家族共分离.
- 一项全面的文献综述分析了有关TBX1突变和表型的现有数据.
主要成果:
- 在患有HCM的个体中发现了TBX1基因 (NM_080647.1:c.3_27dup,p.Met10Alafs167) 中的一种新型异质合体框架转移突变.
- 分离分析证实了TBX1突变与家族内的HCM表型之间的强烈相关性.
- 这项研究代表了第一个将TBX1突变与多变性心肌病症联系起来的报告.
结论:
- 家庭性多变性心肌病 (HCM) 被确定为与TBX1基因突变相关的新型表型.
- 这些发现扩大了已知的TBX1突变及其相关临床表现的范围.
- 需要进一步的研究来阐明TBX1相关的HCM背后的分子机制.
相关概念视频
Genetic Lingo
Overview
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


